Heim002773 • SHE
Chengdu Kanghong Pharma Grp Co Ltd
19,49 ¥
27. sep., 16:29:51 GMT+8 · CNY · SHE · Lagalegir fyrirvarar
HlutabréfSkráð hlutabréf í CN
Við síðustu lokun
18,35 ¥
Dagbil
18,55 ¥ - 19,86 ¥
Árabil
13,15 ¥ - 24,50 ¥
Markaðsvirði
15,45 ma. CNY
Meðalmagn
5,87 m.
V/H-hlutf.
14,79
A/V-hlutfall
1,95%
Aðalkauphöll
SHE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(CNY)jún. 2024Breyting á/á
Tekjur
1,20 ma.16,01%
Rekstrarkostnaður
747,44 m.13,22%
Nettótekjur
318,70 m.29,55%
Hagnaðarhlutfall
26,5311,66%
Hagnaður á hvern hlut
EBITDA
390,64 m.22,49%
Virkt skatthlutfall
15,15%
Heildareignir
Heildarskuldir
(CNY)jún. 2024Breyting á/á
Reiðufé og skammtímafjárfestingar
5,12 ma.26,47%
Heildareignir
8,88 ma.10,71%
Heildarskuldir
719,61 m.-0,96%
Eigið fé alls
8,16 ma.
Útistandandi hlutabréf
919,76 m.
Eiginfjárgengi
2,07
Arðsemi eigna
9,43%
Ávöxtun eigin fjár
10,21%
Breyting á handbæru fé
(CNY)jún. 2024Breyting á/á
Nettótekjur
318,70 m.29,55%
Handbært fé frá rekstri
399,08 m.8,41%
Reiðufé frá fjárfestingum
-172,91 m.-128,44%
Reiðufé frá fjármögnun
-349,68 m.-151,55%
Breyting á handbæru fé
-123,56 m.-114,76%
Frjálst peningaflæði
314,78 m.1,97%
Um
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Stofnsett
3. okt. 1996
Vefsvæði
Starfsfólk
4.289
Leit
Hreinsa leit
Loka leit
Google forrit
Aðalvalmynd